Osteoporosis remains a major public health concern, considering its high prevalence along with its association with osteoporotic fractures. It imposes a heavy burden on the society worldwide as the population ages. This paper aims to provide a brief review on Iranian multicenter osteoporosis studies (IMOS) studies and provide some recommendations for improvement.
IMOS studies were conducted to investigate the prevalence of osteoporosis and related risk factors. This paper provides a general view on the Iranian multicenter osteoporosis studies (IMOS), conducted during last decades.
The results showed a high prevalence of osteoporosis and vitamin D deficiency in the Iranian population. Although the study protocols were mainly similar, some differences were observed in terms of the study population and design. The protocol of IMOS-3 was modified to overcome the setbacks noted in the previous studies; however, it was implemented in two cities with noticeably different socioeconomic and geographical characteristics from five cities where the first phase was conducted, resulting in different lifestyles and habits. Although previous IMOS studies have raised major concerns regarding the high prevalence of osteoporosis and vitamin D deficiency, interpretation should be made with caution given the differences, especially in the surveyed cities. Such discrepancies cause problems in trend analysis, and nationally representative samplings are preferably needed to correctly compare the prevalence of osteoporosis and related risk factors.
Considering the aging population and the importance of osteoporosis and its complication, developing a standard surveillance system to obtain valid and nationally representative estimates is recommended.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Kanis J. WHO technical report. Sheffield: University of Sheffield.. 2007; 66.
Larijani B, et al. Osteoporosis in Iran, overview and management. Iran J Public Health, 2007. p. 1–13.
Ahmadi-Abhari S, Moayyeri A, Abolhassani F. Burden of hip fracture in Iran. Calcif Tissue Int. 2007;80(3):147–53.
Nations U. World population ageing 2017 Highlights. New York: Department of Economic and Social Affairs; 2017.
Reginster J-Y, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(2):4–9.
El-Hajj Fuleihan G, Adib G, Nauroy L. The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. Int Osteoporos Found. 2011. p. 102011–105000.
Salehi I, et al. High prevalence of low bone density in young Iranian healthy individuals. Clin Rheumatol. 2009;28(2):173–7.
Irani AD, et al. Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci. 2013;18(9):759.
Heshmat R, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health. 2008; 37(suppl).
Tabrizi R, et al. High prevalence of vitamin d deficiency among iranian population: A systematic review and meta-analysis. Iran J Med Sci. 2018;43(2):125.
Esteghamati A, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9(1):167.
Hadavi M, et al. Osteoporosis prevalence and t-score discordance between femur and lumbar spine in iran and some related factors: Imos study. Iran J Diabetes Metab. 2015;14(5):305–14.
Meybodi HA, et al. Iranian osteoporosis research network: Background, mission and its role in osteoporosis management. Iran J Public Health. 2008;37(sup):1–6.
Rahnavard Z, et al. Vitamin D deficiency in healthy male population: Results of the Iranian multi-center osteoporosis study. Iran J Public Health. 2010;39(3):45.
Larijani B, et al. Peak bone mass of Iranian population: The Iranian multicenter osteoporosis study. J Clin Densitom. 2006;9(3):367–74.
Keshtkar A, et al. A suggested prototype for assessing bone health. Arch Iran Med. 2015;18(7):411–5.
Khashayar P, et al. The prevalence of osteoporosis in an Iranian population. J Clin Densitom. 2010;13(1):112.
Mohammadi Z, et al. Prevalence of osteoporosis and vitamin D receptor gene polymorphisms (FokI) in an Iranian general population based study (Kurdistan)(IMOS). Med J Islam Repub Iran. 2015;29:238.
Moradzadeh K, et al. Normative values of vitamin D among Iranian population: a population based study. Int J Osteoporos Metab Disord. 2008;1(1):8–15.
Meybodi HA, et al. Association between anthropometric measures and bone mineral density: population-based study. Iran J Public Health. 2011;40(2):18.
Khashayar P, et al. Awareness of osteoporosis among female head of household: an Iranian experience. Arch Osteoporos. 2017;12(1):36.
Zamani M, et al. Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: a systematic review and meta-analysis. Arch Osteoporos. 2018;13(1):129.
Yee JL, Niemeier D. Advantages and disadvantages: Longitudinal vs. repeated cross-section surveys. Proj Battelle. 1996;94(16):7.
Hajipour MJ, et al. Protocol design for large–scale cross–sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9).
Morley JE, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12(6):403–9.
Crepaldi G, Maggi S. Sarcopenia and osteoporosis: a hazardous duet. J Endocrinol Investig. 2005;28(10 Suppl):66–8.
Tarantino U, et al. Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction. JBJS. 2015;97(5):429–37.
Cederholm T, Cruz-Jentoft A, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med. 2013;49(1):111–7.
Hashemi R, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18–22.
Conflict of interest
The authors declare that they have no conflict of interest in the authorship or publication of this contribution.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fahimfar, N., Gharibzadeh, S., Khashayar, P. et al. Iranian Multicenter Osteoporosis Studies (IMOS) during last decade: rationale, main findings, lessons learned and the way forward. J Diabetes Metab Disord (2020). https://doi.org/10.1007/s40200-020-00600-6
- Vitamin D deficiency